Is the tiered immunogenicity testing of biologics the adequate approach in preclinical development?

Title

Is the tiered immunogenicity testing of biologics the adequate approach in preclinical development?

Author

Sauerborn, M.

Publication year

2013

Subject

Triskelion BV
TARA - Toxicology and Risk Assessment
TNO Bedrijven
Biomedical Innovation
Biology
Healthy Living
anti-drug antibodies
biologics
immunoassays
immunogenicity
risk-based assessment
tiered approach

To reference this document use:

http://resolver.tudelft.nl/uuid:64ec3cb3-7e10-42c8-bcce-a5639342a8f6

DOI

https://doi.org/10.4155/bio.13.43

TNO identifier

471472

ISSN

1757-6180

Source

Bioanalysis, 5 (7), 743-746

Document type

article